期刊文献+

前列腺外周带癌的MRI 6分区定位诊断研究 被引量:2

Sextant localization of prostate cancer in peripheral zone by MRI: correlation with systemic biopsy pathology
原文传递
导出
摘要 目的评价MRI 6分区诊断作为1个独立诊断系统时,对前列腺外周带癌的定位、定性诊断效能。方法不提供任何临床资料,由2名有不同诊断经验的诊断者对80例前列腺外周带480个分区进行独立盲法阅片,针对每个分区做出诊断,分为1是癌、2可能是癌、3不清楚、4可能不是癌、5不是癌5个等级,如果诊断结果是癌,则进一步进行分期。将诊断结果和系统穿刺活检病理结果进行对照研究。结果(1)经病理证实的470个分区中205个分区为癌。诊断界值取2时,MRI 6分区诊断和穿刺病理的一致性较好,Kappa值为0.549-0.560,准确度78.1%-78.3%,敏感度69.3%-76.1%,特异度84.9%-80.0%,阳性预测值78.0%-74.6%,阴性预测值78.1%- 81.2%。(2)不同经验的诊断者的ROC曲线下面积分别为0.829±0.020和0.840±0.019,两者间(U=-0.3988,P>0.05)诊断效能差异无统计学意义。结论MRI可用于前列腺癌的定位、定性诊断,但准确性有待进一步提高。 Objective To determine the efficacy of sextant localization of prostate cancer (PCa) in PZ (peripheral zone) by MR Imaging. Methods Fifty-one cases of PCa and 29 cases of benign prostate diseases were enrolled in the study. Each peripheral zone was divided into 6 sections ( left/right bottom, middle and tip ) in the same fashion for biopsy and the characteristics of each sextant was evaluated separately. Being blinded to clinical data, 2 radiologists with different subspecialty experience analyzed MR images of the 480 sections of these 80 cases retrospectively. Each sextant region impression of likelihood for cancer was estimated by the rank of a five-point rating scale ( 1 = definite PCa, 2 = probable PCa, 3 = possible PCa, 4 = probably not PCa, 5 = definitely not PCa). If definite PCa was considered, then it was staged furthermore. Each diagnosis of sextant region was compared with the pathological result of corresponding biopsy site. Result ( 1 ) Four hundred and seventy sections (205 cancerous and 265 benign) were proved by biopsy. The diagnosis efficacy was best when cutoff point was 2. There was moderate consistency between the results of MRI and pathology with the kappa value of 0. 549 - 0. 560. The total accuracy was 78. 1% - 78. 3% with the sensitivity of 69. 3% - 76. 1% and the specificity of 84.9% - 80. 0%. The positive predictive value was 78.0% -74. 6% and the negative predictive value was 78. 1% - 81.2%. (2) The ROC analysis demonstrated that Az with total impression recorded by two readers had not significant difference(0.829±0.020 vs. 0.840±0.019, U= -0.3988,P〉0.05).Conclusion MRI may be an elementary way to localize PCa in PZ, but the diagnosis efficacy need to be improved furthermore.
出处 《中华放射学杂志》 CAS CSCD 北大核心 2006年第7期684-689,共6页 Chinese Journal of Radiology
关键词 前列腺肿瘤 磁共振成像 诊断试验 常规 Prostate neoplasms Magnetic resonance imaging Diagnosis test Routine
  • 相关文献

参考文献6

二级参考文献35

  • 1王霄英,周良平,丁建平,王刚,肖江喜,蒋学祥.中国正常成年男性前列腺的MRS定量分析[J].中国医学影像技术,2003,19(5):576-578. 被引量:24
  • 2王继琛,高玉洁,蒋学祥,李松年,刘赓年.前列腺癌的MRI诊断与分期[J].中华放射学杂志,1996,30(11):741-744. 被引量:27
  • 3Kurhanewicz J, Vigneron DB, Hricak H, et al. Three-dimensional H-1 MR spectroscopic imaging of the in situ human prostate with high(0.24-0.7 cm3) spatial resolution. Radiology, 1996, 198: 795-805.
  • 4Kurhanewicz J, Vigneron DB, Males RG, et al. The prostate: MR imaging and spectroscopy. Radiol Clin North Am, 2000, 38: 115-138.
  • 5van der Kwast TH, Lopes C, Santonja C, et al. Guidelines for processing and reporting of prostatic needle biopsies. J Clin Pathol,2003, 56: 336-340.
  • 6Ochiai A, Babaian RJ. Update on prostate biopsy technique. Curr Opin Urol, 2004, 14: 157-162.
  • 7Bartolozzi C, Crocetti L, Menchi I, et al. Endorectal magnetic resonance imaging in local staging of prostate carcinoma. Abdom Imaging, 2001, 26: 111-122.
  • 8Kurhanewicz J, Swanson MG, Wood PJ, et al. Magnetic resonance imaging and spectroscopic imaging: improved patient selection and potential for metabolic intermediate endpoints in prostate cancer chemoprevention trials. Urology, 2001, 57( Suppl 1 ) : 124-128.
  • 9Hahn P, Smith IC, Leboldus L, et al. The classification of benign and malignant human prostate tissue by multivariate analysis of 1 H magnetic resonance spectra. Cancer Res, 1997, 57: 3398-3401.
  • 10Lowry M, Liney GP, Tumbull LW, et al. Quantification of citrate concentration in the prostate by proton magnetic resonance spectroscopy: zonal and age-related differences. Magn Reson Med,1996, 36 : 352-358.

共引文献188

同被引文献25

  • 1王霄英,周良平,丁建平,李飞宇,山刚志,肖江喜,蒋学祥.RS对中国人前列腺癌鉴别诊断标准的初步研究[J].中国医学影像技术,2004,20(8):1150-1153. 被引量:97
  • 2Mueller-Lisse UG, Swanson MG, Vigneron DB, et al. Timedependent effects of hormone-deprivation therapy on prostate metabolism as detected by combined magnetic resonance imaging and 3D magnetic resonance Med, 2001,46:49-57.
  • 3Mueller-Lisse UG, Swanson spectroscopic imaging. Magn Reson MG, Vigneron DB, et al. Magnetic resonance spectroscopy in patients with locally confined prostate cancer: association of prostatic citrate and metabolic atrophy with time on hormone deprivation therapy, PSA level, and biopsy Gleason score. Eur Radiol, 2007, 17: 371-378.
  • 4Mueller-Lisse UG, Vignemn DB, Hricak H, et al. Localized prostate cancer: effect of hormone deprivation therapy measured by using combined three-dimensional ^1H MR spectroscopy and MR imaging: clinicopathologic case-controlled study. Radiology, 2001, 221: 380-390.
  • 5Pickett B, Kurhanewicz J, Pouliot J, et al. Three-dimensional conformal external beam radiotherapy compared with permanent prostate implantation in low-risk prostate cancer based on endorectal magnetic resonance spectroscopy imaging and prostatespecific antigen level. Int J Radiat Oncol Biol Phys, 2006, 65 : 65-72.
  • 6Pickett B, Kurhanewicz J, Coakley F, et al. Use of MRI and spectroscopy in evaluation of external beam radiotherapy for prostate cancer. Int J Radiat Oncol Biol Phys, 2004, 60: 1047-1055.
  • 7Parivar F, Hricak H, Shinohara K, et al. Detection of locally recurrent prostate cancer after cryosurgery: evaluation by transrectal ultrasound, magnetic resonance imaging, and threedimensional proton magnetic resonance spectroscopy. Urology, 1996, 48: 594-599.
  • 8Kurhanewicz J, Vigneron DB, Hricak H, et al. Prostate cancer: metabolic response to cryosurgery as detected with 3D H-1 MR spectroscopic imaging. Radiology, 1996, 200 : 489-496.
  • 9Sillerud LO, Halliday KR, Griffey RH, et al. In vivo ^13C NMR spectroscopy of the human prostate. Magn Reson Med, 1988, 8 : 224-230.
  • 10Vigneron DB, Hricak H, James TL, et al. Androgen sensitivity of rat prostate carcinoma studied by ^31p NMR spectroscopy, ^1H MR imaging, and ^23Na MR imaging. Magn Reson Med, 1989, 11: 152-160.

引证文献2

二级引证文献23

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部